Chairman Share Purchases
6 November 2024
Alkemy Capital Investments Plc
Chairman Share Purchases
Alkemy Capital Investments plc ("Alkemy") (ALK:LSE) (JV2:FRA) announces that its Chairman Paul Atherley has purchased a total of 86,845 ordinary shares in the Company at an average price of £0.82 per share.
Following these share purchases, Paul Atherley holds 3,400,559 ordinary shares in the Company, representing 38.58% of the Company's issued share capital.
Further information
For further information, please visit Alkemy's website: www.alkemycapital.co.uk or TVL's website www.teesvalleylithium.co.uk.
-Ends-
Alkemy Capital Investments Plc
| Tel: 0207 317 0636 |
Zeus Capital | Tel: 0203 829 5000 |
1 | Details of the person discharging managerial responsibilities / person closely associated | |||||
a) | Name | Paul Atherley | ||||
2 | Reason for Notification | |||||
a) | Position/status | Chairman | ||||
b) | Initial notification/amendment | Initial notification | ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Alkemy Capital Investments Plc | ||||
b) | LEI | 213800NW5GVIRMXSRL48 | ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument | Ordinary shares | ||||
Identification code | GB00BMD6C023 | |||||
b) | Nature of the transaction | Purchase of shares | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information | Price: £0.82 Quantity: 86,845 | ||||
e) | Date of the transaction(s) | 24 October 2024, 25 October 2024, 28 October 2024, 30 October 2024, 31 October 2024 | ||||
f) | Place of the transaction | London Stock Exchange | ||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.